CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹3,134 Cr | ₹2,563 Cr | ₹1,507 Cr | ₹1,031 Cr | ₹975 Cr |
What is the latest Short Term Loans and Advances ratio of CIPLA ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹3,134 Cr |
Mar2023 | ₹2,563 Cr |
Mar2022 | ₹1,507 Cr |
Mar2021 | ₹1,031 Cr |
Mar2020 | ₹975 Cr |
How is Short Term Loans and Advances of CIPLA Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹3,134 Cr | 22.28 | |
Mar2023 | ₹2,563 Cr | 70.07 | |
Mar2022 | ₹1,507 Cr | 46.18 | |
Mar2021 | ₹1,031 Cr | 5.77 | |
Mar2020 | ₹975 Cr | - |
Compare Short Term Loans and Advances of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹118,365.9 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,273.0 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,013.6 Cr | -2% | -6.1% | 49.9% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | -2.6% |
-3.8% |
19.2% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses